{"id":13838,"date":"2021-05-07T22:03:47","date_gmt":"2021-05-08T05:03:47","guid":{"rendered":"https:\/\/www.functionalps.com\/blog\/?p=13838"},"modified":"2021-05-07T22:04:08","modified_gmt":"2021-05-08T05:04:08","slug":"pfizer-nigeria-drug-trial-victims-get-compensation","status":"publish","type":"post","link":"https:\/\/www.functionalps.com\/blog\/2021\/05\/07\/pfizer-nigeria-drug-trial-victims-get-compensation\/","title":{"rendered":"Pfizer: Nigeria drug trial victims get compensation"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.bbc.com\/news\/world-africa-14493277\">Source<\/a><\/p>\n\n\n\n<p><strong>US-based pharmaceutical giant Pfizer has made the first compensation payment to Nigerian families affected by a controversial drug trial 15 years ago.<\/strong><\/p>\n\n\n\n<p>It paid $175,000 (\u00a3108,000) each to four families in the first of a series of payments it is expected to make.<\/p>\n\n\n\n<p>The payouts are part of an out-of-court settlement reached in 2009.<\/p>\n\n\n\n<p>In 1996, 11 children died and dozens were left disabled after Pfizer gave them the experimental anti-meningitis drug, Trovan.<\/p>\n\n\n\n<p>The payouts were made to the parents of four of the children who died.<\/p>\n\n\n\n<p>Their parents told the BBC they welcomed the payment, but it would not replace the loss of their loved ones.<\/p>\n\n\n\n<p>The children were part of a group of 200 given the drug during a meningitis epidemic in the northern city of Kano as part of a medical trial comparing Trovan&#8217;s effectiveness with the established treatment.<\/p>\n\n\n\n<p>For years Pfizer maintained that meningitis &#8211; not the drug &#8211; caused the deaths and disabilities.<\/p>\n\n\n\n<p>But after a lengthy and expensive litigation process, it reached a settlement with the Kano government in northern Nigeria.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">DNA tests<\/h2>\n\n\n\n<p>The trials were carried out in Kano and the state government fought Pfizer on behalf of victims and their families.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter\"><img decoding=\"async\" src=\"https:\/\/ichef.bbci.co.uk\/news\/304\/media\/images\/54553000\/jpg\/_54553381_43068021.jpg\" alt=\"Hajara\"\/><figcaption>image captionHajara, photographed in 2007, survived the trials but became deaf afterwards and is unable to speak<\/figcaption><\/figure><\/div>\n\n\n\n<p>It has taken two years and DNA tests to establish who is entitled to payments, the BBC&#8217;s Jonah Fisher in Lagos says.<\/p>\n\n\n\n<p>It could take another year for payments to be concluded, he says.<\/p>\n\n\n\n<p>Pfizer also agreed to sponsor health projects in Kano as well as creating a fund of $35m to compensate those affected.<\/p>\n\n\n\n<p>Pfizer said it was pleased the four had been compensated.<\/p>\n\n\n\n<p>&#8220;This is the first step in a multi-phase review process by which the independent board of trustees that manages the fund will deliver payment to all other qualified claimants,&#8221; the company said in a statement.<\/p>\n\n\n\n<p>&#8220;We thank them for their commitment and dedication to seeing this process through in the most timely and transparent way possible.&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Source US-based pharmaceutical giant Pfizer has made the first compensation payment to Nigerian families affected by a controversial drug trial 15 years ago. It paid $175,000 (\u00a3108,000) each to four families in the first of a series of payments it is expected to make. The payouts are part of an out-of-court settlement reached in 2009. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-13838","post","type-post","status-publish","format-standard","hentry","category-general"],"_links":{"self":[{"href":"https:\/\/www.functionalps.com\/blog\/wp-json\/wp\/v2\/posts\/13838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.functionalps.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.functionalps.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.functionalps.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.functionalps.com\/blog\/wp-json\/wp\/v2\/comments?post=13838"}],"version-history":[{"count":2,"href":"https:\/\/www.functionalps.com\/blog\/wp-json\/wp\/v2\/posts\/13838\/revisions"}],"predecessor-version":[{"id":13840,"href":"https:\/\/www.functionalps.com\/blog\/wp-json\/wp\/v2\/posts\/13838\/revisions\/13840"}],"wp:attachment":[{"href":"https:\/\/www.functionalps.com\/blog\/wp-json\/wp\/v2\/media?parent=13838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.functionalps.com\/blog\/wp-json\/wp\/v2\/categories?post=13838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.functionalps.com\/blog\/wp-json\/wp\/v2\/tags?post=13838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}